Cramer says Moderna's stumbles highlight some risks of investing in young companies

Jim Cramer
Scott Mlyn | CNBC

Moderna's reduction in its Covid vaccine sales forecast for this year serves as a reminder to investors about some risks of investing in less-established companies, CNBC's Jim Cramer said Thursday.